Usefulness of MMP-9/TIMP-1 in predicting tumor recurrence in patients undergoing curative surgical resection for gastric carcinoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Seo, Yeon Seok | - |
dc.contributor.author | Park, Jong-Jae | - |
dc.contributor.author | Kim, Ji Hoon | - |
dc.contributor.author | Kim, Jin Yong | - |
dc.contributor.author | Yeon, Jong Eun | - |
dc.contributor.author | Kim, Jae Seon | - |
dc.contributor.author | Byun, Kwan Soo | - |
dc.contributor.author | Bak, Young-Tae | - |
dc.date.available | 2020-11-03T12:46:22Z | - |
dc.date.issued | 2007-03 | - |
dc.identifier.issn | 0163-2116 | - |
dc.identifier.issn | 1573-2568 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/18073 | - |
dc.description.abstract | Degradation of the extracellular matrix is an essential step in tumor invasion and metastasis. It involves the actions of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs). We evaluated the expression of MMP-9 and TIMP-1 in gastric carcinomas and the relationship between this expression and tumor recurrence. Eighty patients who had undergone curative surgical resection for gastric carcinoma were included. Resected gastric tissue samples were stained immunohistochemically to evaluate the expression of MMP-9 and TIMP-1. TIMP-1 expression was related to the depth of tumor invasion and lymph node metastasis. The proportion of tumors larger than 5 cm, or displaying muscle layer invasion, and the cumulative incidence of tumor recurrence were significantly elevated in patients with tumors expressing TIMP-1. Furthermore, these measures were lowest in patients with no TIMP-1 expression and highest in patients who only expressed TIMP-1. In conclusion, TIMP-1 expression and the balance between expression of MMP-9 and expression of TIMP-1 may be important indicators of tumor progression and predictors of tumor recurrence. | - |
dc.format.extent | 7 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Kluwer Academic/Plenum Publishers | - |
dc.title | Usefulness of MMP-9/TIMP-1 in predicting tumor recurrence in patients undergoing curative surgical resection for gastric carcinoma | - |
dc.type | Article | - |
dc.publisher.location | 네델란드 | - |
dc.identifier.doi | 10.1007/s10620-006-9535-0 | - |
dc.identifier.scopusid | 2-s2.0-33847197955 | - |
dc.identifier.wosid | 000244306500025 | - |
dc.identifier.bibliographicCitation | Digestive Diseases and Sciences, v.52, no.3, pp 753 - 759 | - |
dc.citation.title | Digestive Diseases and Sciences | - |
dc.citation.volume | 52 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 753 | - |
dc.citation.endPage | 759 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
dc.subject.keywordPlus | TISSUE INHIBITOR | - |
dc.subject.keywordPlus | MATRIX METALLOPROTEINASES | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | METASTASIS | - |
dc.subject.keywordPlus | INVASION | - |
dc.subject.keywordPlus | PLASMA | - |
dc.subject.keywordPlus | INVASIVENESS | - |
dc.subject.keywordPlus | CELLS | - |
dc.subject.keywordAuthor | Gastric cancer | - |
dc.subject.keywordAuthor | Neoplasm recurrence | - |
dc.subject.keywordAuthor | Matrix metalloproteinases | - |
dc.subject.keywordAuthor | Tissue inhibitor of metalloproteinases | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.